Pharmacy Repackaging Systems Market Size, Share, Growth, and Industry Analysis, By Type (Blister Card Packaging Systems, Pouch Packaging Automation Systems, Liquid Medication Packaging Systems, Bottle Filling Automation Systems) By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Regional Forecast From 2025 To 2034

Last Updated: 08 September 2025
SKU ID: 29640292

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

PHARMACY REPACKAGING SYSTEMS MARKET OVERVIEW

The global Pharmacy Repackaging Systems Market size stood at USD 1.55 billion in 2025, growing further to USD 2.81 billion by 2034 at an estimated CAGR of 6.86% from 2025 to 2034.

The United States Pharmacy Repackaging Systems Market size is projected at USD 0.53366 billion in 2025, the Europe Pharmacy Repackaging Systems Market size is projected at USD 0.36408 billion in 2025, and the China Pharmacy Repackaging Systems Market size is projected at USD 0.44856 billion in 2025.

 The global COVID-19 pandemic has been unprecedented and staggering, with pharmacy repackaging systems experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden spike in CAGR is attributable to demand returning to pre-pandemic levels once the pandemic is over.

Pharmacy repackaging means repackaging purchased medications for safety.

The growing rate of medication errors and related increased death rates. Growing demand to make regulations pertaining to patient safety extra stringent and improvement in healthcare & pharmaceutical services is anticipated to accelerate market growth. The huge adoption of advanced technology solutions in the healthcare sector is predicted to fuel market progress. Medical packing is primarily depending on the prevalence of communicable and non-communicable diseases. Packaging has several advantages, such as storing, securing, storing, and protecting drugs. The adoption of the packing system helps to increase medicine life shells, and huge demand for packing from the pharmaceutical sector is predicted to drive market progress in the forthcoming years. On the contrary, the growing number of counterfeit medicines means fake drugs with no active ingredients are anticipated to restrict the market growth. Further, the rise in third-shift packaging is projected to harm market progress in the upcoming years.

KEY FINDINGS

  • Market Size and Growth: USD 1.55 billion in 2025, growing further to USD 2.81 billion by 2034 at an estimated CAGR of 6.86% from 2025 to 2034.
  • Key Market Driver: Guidance outlines conditions under which pharmacies and outsourcing facilities can repackage certain human drug products without violating provisions of the Federal Food, Drug, and Cosmetic Act.
  • Major Market Restraint: Repackaging practices conflicting with approved product labeling could result in drug product degradation and adverse events associated with impurities or lack of efficacy.
  • Emerging Trends: State-licensed pharmacy, federal facility, or outsourcing facility repackages certain human drug products .
  • Regional Leadership: Guidance documents indicate that certain sterile compounding methods that are not addressed in the guidance may be relevant to regional practices in pharmacy repackaging .
  • Competitive Landscape: The 42% market cover Pearson Medical Technologies, Kirby Lester, Parata Systems, TCGRx, Swisslog Holding, Yuyama, Omnicell, etc.
  • Market Segmentation: 35% Repackaging is performed by a range of entities, including facilities that specialize in repackaging drug products, and pharmacies, including pharmacies in hospitals and health systems .
  • Recent Development: final guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities describes the conditions under which FDA does not intend to take action

COVID-19 IMPACT

Growing Demand for Online Shopping During the Pandemic Period to Surge Market Growth  

Several businesses were impacted due to the outbreak of the COVID-19 pandemic, resulting in the scarcity of raw materials and disrupted supply chains. Travel bans and fluctuation of raw material prices hamper the market growth.

On the contrary, allowance for essential services and government regulations support operational activities to manufacture healthcare products. Huge adoption of generic drugs and medicines accelerated the adoption of pharmacy repacking systems.

LATEST TRENDS

Development of Novel Drug Packing Systems to Accelerate Market Progress

A growing interest in the development of novel drug packaging systems in pharmaceutical sector. The methods include prefilled syringes and prefilled inhalers. The products are commonly single-dose vaccine units. The packaging systems are usually replacements for traditional vials and syringes. The inhalers are designed typically to protect packed drugs from external surroundings. The huge adoption of advanced technology solutions in the healthcare sector is predicted to fuel market progress. Medical packing is primarily depending on the prevalence of communicable and non-communicable diseases. Packaging has several advantages, such as storing, securing, storing, and protecting drugs. The adoption of the packing system helps to increase medicine life shell, and huge demand for packing from the pharmaceutical sector is predicted to drive pharmacy repackaging systems market progress in the forthcoming years.

PHARMACY REPACKAGING SYSTEMS MARKET SEGMENTATION

By Type

Based on type, the market is divided into blister card packaging systems, pouch packaging automation systems, liquid medication packaging systems, bottle filling automation systems, and pharmacy repackaging systems

Blister card packaging systems are expected to be the top part of type segmentation

By Application

Based on the application, the market is divided into hospital pharmacies, retail pharmacies, and online pharmacies.

Hospital pharmacies are expected to be the top part of application segmentation.

DRIVING FACTORS

Huge Demand from Pharmaceutical Sector to Boost Packaging Systems Adoption

The pharmaceutical sector is growing rapidly due to the increased population and developing economies. Rise in awareness in the healthcare sector and huge adoption of advanced manufacturing processes. The growing need for biological products and the growing prevalence of asthma and diabetes are estimated to propel market growth. The growing rate of medication errors and related increased death rates. Growing demand to make regulations pertaining to patient safety extra stringent and improvement in healthcare & pharmaceutical services is anticipated to accelerate market growth. Rising spending in public healthcare systems is projected to surge market growth in the upcoming years.

Growing Adoption of Generic Drugs to Improve Market Growth

Increasing adoption of generic drugs due to low cost in developing regions is expected to fuel market growth. Several investments by key players to manufacture generic drugs and high need for generic drugs among the growing population are predicted to drive market progress. Increased demand to pack and protect during carriage and storage is anticipated to accelerate market progress in the forthcoming years.

  • The FDA's guidance documents indicate that certain sterile compounding methods that are not addressed in the guidance may be relevant to driving factors in pharmacy repackaging .
  • The Outsourcing Facilities Association (OFA) represents FDA-registered outsourcing facilities operating pursuant to Section 503B of the Federal Food, Drug, and Cosmetic Act, highlighting driving factors in the repackaging sector .

RESTRAINING FACTORS

Rise in Fake Medicines Manufacturing to Obstruct Market Growth

A growing number of counterfeit medicines means fake drugs with no active ingredients are anticipated to restrict the market growth. Further, the rise in third-shift packaging is projected to harm market progress in the upcoming years.

  • The FDA has issued guidance stating that repackaging practices that conflict with approved product labeling could result in drug product degradation and adverse events associated with impurities in the product or lack of efficacy .
  • The FDA's final guidance on repackaging of certain human drug products by pharmacies and outsourcing facilities describes the conditions under which FDA does not intend to take action for violations of certain provisions of the Federal Food, Drug, and Cosmetic Act when a state-licensed pharmacy, federal facility, or outsourcing facility repackages certain human drug products .

PHARMACY REPACKAGING SYSTEMS MARKET REGIONAL INSIGHTS

Rising Pharmaceutical Industry and Presence of Most Significant Contributor in North America to Drive Market Share

North America is anticipated to hold the largest pharmacy repackaging systems market share owing to the rising pharmaceutical industry and the presence of the most significant contributor. Increased healthcare spending, a growing need for primary packaging products, and increasing disease prevalence in the region are predicted to drive market growth. 

Europe is projected to account for the second largest position across the globe owing to the growing adoption of updated regulations and the huge need for containers, vials, plastic bottles, prefilled syringes, and ampoules, which is anticipated to boost market progress. 

KEY INDUSTRY PLAYERS

Leading Players Adopt New Strategies to Stay Competitive

The report covers information about the list of market players and their latest development in the industry. The information includes mergers, partnerships, acquisitions, technological developments, and production lines. Other aspects examined for this market include complete research on companies producing and introducing the latest products, regions they conduct their operations in, automation, technology adoption, generating the most revenue, and making a difference with their products.

  • Pearson Medical Technologies: A leader in pharmacy automation, Pearson Medical Technologies offers a range of repackaging systems designed to improve efficiency and accuracy in medication dispensing.
  • Kirby Lester: Known for its innovative pharmacy automation solutions, Kirby Lester provides systems that enhance medication safety and workflow efficiency.

List of Top Pharmacy Repackaging Systems Companies

  • Pearson Medical Technologies
  • Kirby Lester
  • Parata Systems
  • TCGRx
  • Swisslog Holding
  • Yuyama
  • Omnicell
  • BD
  • Takazono Corporation
  • ARxIUM

REPORT COVERAGE

This research profiles a report with general studies that explain the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by examining the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, and others. This analysis is subject to alteration if the key players and probable analysis of market dynamics change.

Pharmacy Repackaging Systems Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 1.55 Billion in 2025

Market Size Value By

US$ 2.81 Billion by 2034

Growth Rate

CAGR of 6.86% from 2025 to 2034.

Forecast Period

2025TO2034.

Base Year

2024

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Blister Card Packaging Systems
  • Pouch Packaging Automation Systems
  • Liquid Medication Packaging Systems
  • Bottle Filling Automation Systems

By Application

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

FAQs